REPORT ID 7083

Global RNAi for Therapeutic Market Research Report 2017

Publish Date
2-Nov-17
Pages
118
Format
Electronic (PDF)

In this report, the global RNAi for Therapeutic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of RNAi for Therapeutic in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global RNAi for Therapeutic market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Alnylam Pharmaceuticals
    Arbutus Biopharma (Tekmira)
    Arrowhead Research
    Dicerna Pharmaceuticals
    Mirna Therapeutics
    Quark Pharmaceuticals
    RXi Pharmaceuticals
    Silence Therapeutics
    Benitec Biopharma
    Miragen Therapeutics
    Sylentis
    Gradalis
    Sirnaomics
    Silenseed
    Arcturus Therapeutics
    Ariz Biopharma
    Celsion Corporation
    Ascletis Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    siRNA
    miRNA
    shRNA
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Cancer
    Cardiovascular
    HBV
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global RNAi for Therapeutic Market Research Report 2017
1 RNAi for Therapeutic Market Overview
    1.1 Product Overview and Scope of RNAi for Therapeutic
    1.2 RNAi for Therapeutic Segment by Type (Product Category)
        1.2.1 Global RNAi for Therapeutic Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global RNAi for Therapeutic Production Market Share by Type (Product Category) in 2016
        1.2.3 siRNA
        1.2.4 miRNA
        1.2.5 shRNA
    1.3 Global RNAi for Therapeutic Segment by Application
        1.3.1 RNAi for Therapeutic Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Cancer
        1.3.3 Cardiovascular
        1.3.4 HBV
        1.3.5 Other
    1.4 Global RNAi for Therapeutic Market by Region (2012-2022)
        1.4.1 Global RNAi for Therapeutic Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of RNAi for Therapeutic (2012-2022)
        1.5.1 Global RNAi for Therapeutic Revenue Status and Outlook (2012-2022)
        1.5.2 Global RNAi for Therapeutic Capacity, Production Status and Outlook (2012-2022)

2 Global RNAi for Therapeutic Market Competition by Manufacturers
    2.1 Global RNAi for Therapeutic Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global RNAi for Therapeutic Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global RNAi for Therapeutic Production and Share by Manufacturers (2012-2017)
    2.2 Global RNAi for Therapeutic Revenue and Share by Manufacturers (2012-2017)
    2.3 Global RNAi for Therapeutic Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers RNAi for Therapeutic Manufacturing Base Distribution, Sales Area and Product Type
    2.5 RNAi for Therapeutic Market Competitive Situation and Trends
        2.5.1 RNAi for Therapeutic Market Concentration Rate
        2.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global RNAi for Therapeutic Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global RNAi for Therapeutic Capacity and Market Share by Region (2012-2017)
    3.2 Global RNAi for Therapeutic Production and Market Share by Region (2012-2017)
    3.3 Global RNAi for Therapeutic Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global RNAi for Therapeutic Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global RNAi for Therapeutic Consumption by Region (2012-2017)
    4.2 North America RNAi for Therapeutic Production, Consumption, Export, Import (2012-2017)
    4.3 Europe RNAi for Therapeutic Production, Consumption, Export, Import (2012-2017)
    4.4 China RNAi for Therapeutic Production, Consumption, Export, Import (2012-2017)
    4.5 Japan RNAi for Therapeutic Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia RNAi for Therapeutic Production, Consumption, Export, Import (2012-2017)
    4.7 India RNAi for Therapeutic Production, Consumption, Export, Import (2012-2017)

5 Global RNAi for Therapeutic Production, Revenue (Value), Price Trend by Type
    5.1 Global RNAi for Therapeutic Production and Market Share by Type (2012-2017)
    5.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
    5.3 Global RNAi for Therapeutic Price by Type (2012-2017)
    5.4 Global RNAi for Therapeutic Production Growth by Type (2012-2017)

6 Global RNAi for Therapeutic Market Analysis by Application
    6.1 Global RNAi for Therapeutic Consumption and Market Share by Application (2012-2017)
    6.2 Global RNAi for Therapeutic Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global RNAi for Therapeutic Manufacturers Profiles/Analysis
    7.1 Alnylam Pharmaceuticals
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 RNAi for Therapeutic Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Arbutus Biopharma (Tekmira)
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 RNAi for Therapeutic Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Arrowhead Research
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 RNAi for Therapeutic Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Arrowhead Research RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Dicerna Pharmaceuticals
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 RNAi for Therapeutic Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Mirna Therapeutics
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 RNAi for Therapeutic Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Mirna Therapeutics RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Quark Pharmaceuticals
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 RNAi for Therapeutic Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Quark Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 RXi Pharmaceuticals
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 RNAi for Therapeutic Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 RXi Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Silence Therapeutics
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 RNAi for Therapeutic Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Silence Therapeutics RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Benitec Biopharma
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 RNAi for Therapeutic Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Benitec Biopharma RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Miragen Therapeutics
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 RNAi for Therapeutic Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Miragen Therapeutics RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Sylentis
    7.12 Gradalis
    7.13 Sirnaomics
    7.14 Silenseed
    7.15 Arcturus Therapeutics
    7.16 Ariz Biopharma
    7.17 Celsion Corporation
    7.18 Ascletis Pharmaceuticals

8 RNAi for Therapeutic Manufacturing Cost Analysis
    8.1 RNAi for Therapeutic Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of RNAi for Therapeutic

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 RNAi for Therapeutic Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global RNAi for Therapeutic Market Forecast (2017-2022)
    12.1 Global RNAi for Therapeutic Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global RNAi for Therapeutic Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global RNAi for Therapeutic Price and Trend Forecast (2017-2022)
    12.2 Global RNAi for Therapeutic Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America RNAi for Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe RNAi for Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China RNAi for Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan RNAi for Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia RNAi for Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India RNAi for Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global RNAi for Therapeutic Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global RNAi for Therapeutic Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer